Clostridium Difficile News and Research

RSS
Clostridium difficile is a type of bacterium found in human and animal waste. Clostridium difficile is a common cause of diarrhea that occurs in hospitals. It can also cause diarrhea or other intestinal disorders in patients treated with antibiotics.
Merck hosts R&D and Business Briefing

Merck hosts R&D and Business Briefing

Proton pump inhibitor use associated with fracture risk in postmenopausal women

Proton pump inhibitor use associated with fracture risk in postmenopausal women

MBPs offer no clinical benefit to patients undergoing PD: Research team

MBPs offer no clinical benefit to patients undergoing PD: Research team

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

FDA's call for further review of pirfenidone disappointing for Pulmonary Fibrosis patients, says CPF

Results from STEALTH C-3 clinical trial of nitazoxanide presented at DDW 2010

Results from STEALTH C-3 clinical trial of nitazoxanide presented at DDW 2010

New findings show seaweed extract inhibits H1N1 virus

New findings show seaweed extract inhibits H1N1 virus

Second fidaxomicin Phase 3 clinical study data in patients with CDI to be presented at DDW 2010

Second fidaxomicin Phase 3 clinical study data in patients with CDI to be presented at DDW 2010

Salix Pharmaceuticals announces novel patient and health care provider support program for HE

Salix Pharmaceuticals announces novel patient and health care provider support program for HE

ViroPharma initiates multi-dose Phase 2 study of Cinryze in patients with HAE

ViroPharma initiates multi-dose Phase 2 study of Cinryze in patients with HAE

International Day for Fighting Infection focuses on hospital infection control

International Day for Fighting Infection focuses on hospital infection control

Data on ConvaTec's medical devices to be presented at SAWC/WHS 2010

Data on ConvaTec's medical devices to be presented at SAWC/WHS 2010

Novel instrument may help limit spread of diarrhoea-causing bacteria

Novel instrument may help limit spread of diarrhoea-causing bacteria

Hospital acquired infections on the increase

Hospital acquired infections on the increase

Automated UV radiation helps decontaminate healthcare-associated pathogens

Automated UV radiation helps decontaminate healthcare-associated pathogens

Phase I study of Affinium Pharmaceuticals' AFN-1252 for MRSA initiated

Phase I study of Affinium Pharmaceuticals' AFN-1252 for MRSA initiated

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Optimer Pharmaceuticals announces results from second Phase 3 clinical study of fidaxomicin

Superbugs on the decline in Scottish hospitals

Superbugs on the decline in Scottish hospitals

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

Cubist Pharmaceuticals initiates dosing in Phase 2 trial with CB-183,315 for diarrhea due to CDAD

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Cepheid to launch GeneXpert Infinity-48 in Europe at 20th ECCMID

Optimer Pharmaceuticals to present data from fidaxomicin Phase 3 studies at 20th ECCMID

Optimer Pharmaceuticals to present data from fidaxomicin Phase 3 studies at 20th ECCMID